Open access · CC-BY
via OpenAlex
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Marta Pajares, Ana I. Rojo, Gina Manda, Lisardo Boscá, Antonio Cuadrado
Cells · 2020 · ▲ 755 citations
Abstract
Parkinson’s disease (PD) is a common neurodegenerative disorder primarily characterized by the death of dopaminergic neurons that project from the substantia nigra pars compacta. Although the molecular bases for PD development are still little defined, extensive evidence from human samples and animal models support the involvement of inflammation in onset or progression. However, the exact trigger for this response remains unclear. Here, we provide a systematic review of the cellular mediators, i.e., microglia, astroglia and endothelial cells. We also discuss the genetic and transcriptional control of inflammation in PD and the immunomodulatory role of dopamine and reactive oxygen species. Finally, we summarize the preclinical and clinical approaches targeting neuroinflammation in PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cells9071687
- Canonical
- link ↗
- Fetched
- 2026-06-05 MST
Cite this
APA
Pajares, M., Rojo, A.I., Manda, G., Boscá, L., & Cuadrado, A. (2020). Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications. <em>Cells</em>. https://doi.org/10.3390/cells9071687
Vancouver
Pajares M, Rojo AI, Manda G, Boscá L, Cuadrado A. Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications. Cells. 2020. doi:10.3390/cells9071687.
BibTeX
@article{marta2020Inflam,
title = {Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications},
author = {Marta Pajares and Ana I. Rojo and Gina Manda and Lisardo Boscá and Antonio Cuadrado},
journal = {Cells},
year = {2020},
doi = {10.3390/cells9071687},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurological Sciences 2019
Citation only
Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis
Neural Regeneration Research 2024
Open access · CC-BY
Alpha-synuclein-induced upregulation of SKI family transcriptional corepressor 1: A new player in aging and Parkinson’s disease?
Neurobiology of Disease 2012
Preprint · CC-BY
Colonic inflammation in Parkinson's disease
Antioxidants 2025
Open access · CC-BY
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons
Journal of Neuroscience 2016
Open access · CC-BY
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
Nature 2019
Citation only